سعر كوفابرافير 200مجم 40 كبسولة (للمستشفيات فقط) 2026

Covapravir 200 mg 40 caps.(hospital only): Molnupiravir (Eipico).

• Treatment of mild-to-moderate COVID-19 in adults at high risk for progression to severe disease, for whom alternative COVID-19 treatment options are not accessible or clinically appropriate (US LAGEVRIO EUA context). Not a substitute for vaccination.Population: Adults with mild-moderate COVID-19 at high riskDailyMed (U.S. National Library of Medicine)

• No contraindications identified based on the limited available data in the US EUA text reviewed; hypersensitivity reactions including anaphylaxis have been reported — discontinue if severe reaction occurs.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Embryo-fetal toxicity: not recommended during pregnancy. Advise contraception during treatment and for 4 days after the last dose (females of reproductive potential); males of reproductive potential use reliable contraception during and for at least 3 months after (US label). Hypersensitivity reactions reported.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Not recommended for use during pregnancy based on animal findings of embryo-fetal toxicity (US LAGEVRIO).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Molnupiravir: Prodrug of N-hydroxycytidine (NHC); incorporates into viral RNA causing lethal mutagenesis of SARS-CoV-2.